nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—CHRM3—Ipratropium bromide—asthma	0.0754	0.113	CbGbCtD
Cevimeline—CHRM1—Ipratropium bromide—asthma	0.0656	0.0986	CbGbCtD
Cevimeline—CHRM3—Tiotropium—asthma	0.0572	0.0859	CbGbCtD
Cevimeline—CHRM1—Tiotropium—asthma	0.0497	0.0748	CbGbCtD
Cevimeline—CYP2D6—Ciclesonide—asthma	0.0266	0.04	CbGbCtD
Cevimeline—CYP2D6—Ipratropium bromide—asthma	0.0221	0.0332	CbGbCtD
Cevimeline—CYP3A4—Fluticasone furoate—asthma	0.0208	0.0312	CbGbCtD
Cevimeline—CYP2D6—Zafirlukast—asthma	0.0194	0.0292	CbGbCtD
Cevimeline—CYP2D6—Arformoterol—asthma	0.0188	0.0282	CbGbCtD
Cevimeline—CYP2D6—Formoterol—asthma	0.0188	0.0282	CbGbCtD
Cevimeline—CYP3A4—Budesonide—asthma	0.0185	0.0278	CbGbCtD
Cevimeline—CYP3A4—Indacaterol—asthma	0.0169	0.0254	CbGbCtD
Cevimeline—CYP3A4—Ciclesonide—asthma	0.0169	0.0254	CbGbCtD
Cevimeline—CYP2D6—Tiotropium—asthma	0.0167	0.0251	CbGbCtD
Cevimeline—CYP3A4—Salmeterol—asthma	0.0157	0.0237	CbGbCtD
Cevimeline—CYP3A4—Salbutamol—asthma	0.0157	0.0237	CbGbCtD
Cevimeline—CYP3A4—Flunisolide—asthma	0.0157	0.0237	CbGbCtD
Cevimeline—CYP2D6—Theophylline—asthma	0.015	0.0225	CbGbCtD
Cevimeline—CYP2D6—Loratadine—asthma	0.0142	0.0214	CbGbCtD
Cevimeline—CYP3A4—Zileuton—asthma	0.014	0.0211	CbGbCtD
Cevimeline—CYP3A4—Ipratropium bromide—asthma	0.014	0.0211	CbGbCtD
Cevimeline—CYP3A4—Fluticasone Propionate—asthma	0.0134	0.0201	CbGbCtD
Cevimeline—CYP3A4—Zafirlukast—asthma	0.0123	0.0186	CbGbCtD
Cevimeline—CYP3A4—Tiotropium—asthma	0.0106	0.016	CbGbCtD
Cevimeline—CYP3A4—Aminophylline—asthma	0.0101	0.0152	CbGbCtD
Cevimeline—CYP3A4—Theophylline—asthma	0.00953	0.0143	CbGbCtD
Cevimeline—CYP3A4—Loratadine—asthma	0.00904	0.0136	CbGbCtD
Cevimeline—CYP3A4—Montelukast—asthma	0.00904	0.0136	CbGbCtD
Cevimeline—CYP3A4—Methylprednisolone—asthma	0.00827	0.0124	CbGbCtD
Cevimeline—CYP3A4—Triamcinolone—asthma	0.00626	0.00942	CbGbCtD
Cevimeline—CYP3A4—Betamethasone—asthma	0.00537	0.00808	CbGbCtD
Cevimeline—CYP3A4—Prednisolone—asthma	0.0053	0.00797	CbGbCtD
Cevimeline—CYP3A4—Hydrocortisone—asthma	0.00503	0.00756	CbGbCtD
Cevimeline—CYP3A4—Prednisone—asthma	0.00501	0.00753	CbGbCtD
Cevimeline—CYP2D6—Dexamethasone—asthma	0.00492	0.00739	CbGbCtD
Cevimeline—CYP3A4—Dexamethasone—asthma	0.00313	0.0047	CbGbCtD
Cevimeline—Myalgia—Hydrocortisone—asthma	3.24e-05	0.000113	CcSEcCtD
Cevimeline—Hallucination—Prednisone—asthma	3.23e-05	0.000113	CcSEcCtD
Cevimeline—Malaise—Triamcinolone—asthma	3.23e-05	0.000113	CcSEcCtD
Cevimeline—Anxiety—Hydrocortisone—asthma	3.23e-05	0.000113	CcSEcCtD
Cevimeline—Malaise—Methylprednisolone—asthma	3.22e-05	0.000112	CcSEcCtD
Cevimeline—Vertigo—Triamcinolone—asthma	3.22e-05	0.000112	CcSEcCtD
Cevimeline—Syncope—Triamcinolone—asthma	3.21e-05	0.000112	CcSEcCtD
Cevimeline—Vertigo—Methylprednisolone—asthma	3.21e-05	0.000112	CcSEcCtD
Cevimeline—Syncope—Methylprednisolone—asthma	3.2e-05	0.000112	CcSEcCtD
Cevimeline—Discomfort—Hydrocortisone—asthma	3.2e-05	0.000112	CcSEcCtD
Cevimeline—Nausea—Budesonide—asthma	3.19e-05	0.000111	CcSEcCtD
Cevimeline—Oedema—Prednisolone—asthma	3.18e-05	0.000111	CcSEcCtD
Cevimeline—Loss of consciousness—Triamcinolone—asthma	3.15e-05	0.00011	CcSEcCtD
Cevimeline—Loss of consciousness—Methylprednisolone—asthma	3.14e-05	0.00011	CcSEcCtD
Cevimeline—Shock—Prednisolone—asthma	3.13e-05	0.000109	CcSEcCtD
Cevimeline—Cough—Triamcinolone—asthma	3.13e-05	0.000109	CcSEcCtD
Cevimeline—Oedema—Hydrocortisone—asthma	3.1e-05	0.000108	CcSEcCtD
Cevimeline—Convulsion—Triamcinolone—asthma	3.1e-05	0.000108	CcSEcCtD
Cevimeline—Tachycardia—Prednisolone—asthma	3.1e-05	0.000108	CcSEcCtD
Cevimeline—Convulsion—Methylprednisolone—asthma	3.1e-05	0.000108	CcSEcCtD
Cevimeline—Hypertension—Triamcinolone—asthma	3.09e-05	0.000108	CcSEcCtD
Cevimeline—Hypertension—Methylprednisolone—asthma	3.09e-05	0.000108	CcSEcCtD
Cevimeline—Infection—Hydrocortisone—asthma	3.08e-05	0.000108	CcSEcCtD
Cevimeline—Hyperhidrosis—Prednisolone—asthma	3.07e-05	0.000107	CcSEcCtD
Cevimeline—Shock—Hydrocortisone—asthma	3.05e-05	0.000107	CcSEcCtD
Cevimeline—Myalgia—Triamcinolone—asthma	3.05e-05	0.000106	CcSEcCtD
Cevimeline—Nervous system disorder—Hydrocortisone—asthma	3.04e-05	0.000106	CcSEcCtD
Cevimeline—Myalgia—Methylprednisolone—asthma	3.04e-05	0.000106	CcSEcCtD
Cevimeline—Arthralgia—Methylprednisolone—asthma	3.04e-05	0.000106	CcSEcCtD
Cevimeline—Eye disorder—Prednisone—asthma	3.04e-05	0.000106	CcSEcCtD
Cevimeline—Anxiety—Methylprednisolone—asthma	3.03e-05	0.000106	CcSEcCtD
Cevimeline—Tachycardia—Hydrocortisone—asthma	3.03e-05	0.000106	CcSEcCtD
Cevimeline—Flushing—Prednisone—asthma	3.02e-05	0.000105	CcSEcCtD
Cevimeline—Skin disorder—Hydrocortisone—asthma	3.02e-05	0.000105	CcSEcCtD
Cevimeline—Ill-defined disorder—Betamethasone—asthma	3.02e-05	0.000105	CcSEcCtD
Cevimeline—Ill-defined disorder—Dexamethasone—asthma	3.02e-05	0.000105	CcSEcCtD
Cevimeline—Discomfort—Triamcinolone—asthma	3.01e-05	0.000105	CcSEcCtD
Cevimeline—Discomfort—Methylprednisolone—asthma	3.01e-05	0.000105	CcSEcCtD
Cevimeline—Hyperhidrosis—Hydrocortisone—asthma	3e-05	0.000105	CcSEcCtD
Cevimeline—Anorexia—Hydrocortisone—asthma	2.96e-05	0.000103	CcSEcCtD
Cevimeline—Angiopathy—Prednisone—asthma	2.95e-05	0.000103	CcSEcCtD
Cevimeline—Confusional state—Methylprednisolone—asthma	2.94e-05	0.000103	CcSEcCtD
Cevimeline—Malaise—Dexamethasone—asthma	2.93e-05	0.000102	CcSEcCtD
Cevimeline—Malaise—Betamethasone—asthma	2.93e-05	0.000102	CcSEcCtD
Cevimeline—Oedema—Triamcinolone—asthma	2.92e-05	0.000102	CcSEcCtD
Cevimeline—Vertigo—Betamethasone—asthma	2.92e-05	0.000102	CcSEcCtD
Cevimeline—Vertigo—Dexamethasone—asthma	2.92e-05	0.000102	CcSEcCtD
Cevimeline—Syncope—Dexamethasone—asthma	2.91e-05	0.000102	CcSEcCtD
Cevimeline—Syncope—Betamethasone—asthma	2.91e-05	0.000102	CcSEcCtD
Cevimeline—Arrhythmia—Prednisone—asthma	2.9e-05	0.000101	CcSEcCtD
Cevimeline—Infection—Triamcinolone—asthma	2.9e-05	0.000101	CcSEcCtD
Cevimeline—Hypotension—Hydrocortisone—asthma	2.9e-05	0.000101	CcSEcCtD
Cevimeline—Infection—Methylprednisolone—asthma	2.9e-05	0.000101	CcSEcCtD
Cevimeline—Shock—Triamcinolone—asthma	2.88e-05	0.0001	CcSEcCtD
Cevimeline—Insomnia—Prednisolone—asthma	2.87e-05	0.0001	CcSEcCtD
Cevimeline—Alopecia—Prednisone—asthma	2.87e-05	0.0001	CcSEcCtD
Cevimeline—Shock—Methylprednisolone—asthma	2.87e-05	0.0001	CcSEcCtD
Cevimeline—Nervous system disorder—Methylprednisolone—asthma	2.86e-05	9.98e-05	CcSEcCtD
Cevimeline—Loss of consciousness—Betamethasone—asthma	2.86e-05	9.97e-05	CcSEcCtD
Cevimeline—Loss of consciousness—Dexamethasone—asthma	2.86e-05	9.97e-05	CcSEcCtD
Cevimeline—Paraesthesia—Prednisolone—asthma	2.85e-05	9.96e-05	CcSEcCtD
Cevimeline—Tachycardia—Triamcinolone—asthma	2.85e-05	9.95e-05	CcSEcCtD
Cevimeline—Tachycardia—Methylprednisolone—asthma	2.85e-05	9.93e-05	CcSEcCtD
Cevimeline—Skin disorder—Methylprednisolone—asthma	2.83e-05	9.88e-05	CcSEcCtD
Cevimeline—Malnutrition—Prednisone—asthma	2.83e-05	9.87e-05	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Hydrocortisone—asthma	2.83e-05	9.87e-05	CcSEcCtD
Cevimeline—Hyperhidrosis—Triamcinolone—asthma	2.83e-05	9.86e-05	CcSEcCtD
Cevimeline—Hyperhidrosis—Methylprednisolone—asthma	2.82e-05	9.84e-05	CcSEcCtD
Cevimeline—Convulsion—Betamethasone—asthma	2.82e-05	9.82e-05	CcSEcCtD
Cevimeline—Convulsion—Dexamethasone—asthma	2.82e-05	9.82e-05	CcSEcCtD
Cevimeline—Insomnia—Hydrocortisone—asthma	2.81e-05	9.8e-05	CcSEcCtD
Cevimeline—Hypertension—Dexamethasone—asthma	2.81e-05	9.79e-05	CcSEcCtD
Cevimeline—Hypertension—Betamethasone—asthma	2.81e-05	9.79e-05	CcSEcCtD
Cevimeline—Paraesthesia—Hydrocortisone—asthma	2.79e-05	9.73e-05	CcSEcCtD
Cevimeline—Myalgia—Dexamethasone—asthma	2.77e-05	9.65e-05	CcSEcCtD
Cevimeline—Myalgia—Betamethasone—asthma	2.77e-05	9.65e-05	CcSEcCtD
Cevimeline—Anxiety—Betamethasone—asthma	2.76e-05	9.62e-05	CcSEcCtD
Cevimeline—Anxiety—Dexamethasone—asthma	2.76e-05	9.62e-05	CcSEcCtD
Cevimeline—Discomfort—Betamethasone—asthma	2.73e-05	9.54e-05	CcSEcCtD
Cevimeline—Discomfort—Dexamethasone—asthma	2.73e-05	9.54e-05	CcSEcCtD
Cevimeline—Dyspepsia—Hydrocortisone—asthma	2.73e-05	9.53e-05	CcSEcCtD
Cevimeline—Hypotension—Methylprednisolone—asthma	2.73e-05	9.51e-05	CcSEcCtD
Cevimeline—Pain—Prednisolone—asthma	2.72e-05	9.48e-05	CcSEcCtD
Cevimeline—Decreased appetite—Hydrocortisone—asthma	2.7e-05	9.42e-05	CcSEcCtD
Cevimeline—Fatigue—Hydrocortisone—asthma	2.68e-05	9.34e-05	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Triamcinolone—asthma	2.66e-05	9.29e-05	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Methylprednisolone—asthma	2.66e-05	9.27e-05	CcSEcCtD
Cevimeline—Pain—Hydrocortisone—asthma	2.65e-05	9.26e-05	CcSEcCtD
Cevimeline—Oedema—Dexamethasone—asthma	2.65e-05	9.25e-05	CcSEcCtD
Cevimeline—Oedema—Betamethasone—asthma	2.65e-05	9.25e-05	CcSEcCtD
Cevimeline—Insomnia—Triamcinolone—asthma	2.64e-05	9.22e-05	CcSEcCtD
Cevimeline—Insomnia—Methylprednisolone—asthma	2.64e-05	9.2e-05	CcSEcCtD
Cevimeline—Infection—Dexamethasone—asthma	2.63e-05	9.19e-05	CcSEcCtD
Cevimeline—Infection—Betamethasone—asthma	2.63e-05	9.19e-05	CcSEcCtD
Cevimeline—Ill-defined disorder—Prednisone—asthma	2.63e-05	9.16e-05	CcSEcCtD
Cevimeline—Paraesthesia—Triamcinolone—asthma	2.62e-05	9.16e-05	CcSEcCtD
Cevimeline—Feeling abnormal—Prednisolone—asthma	2.62e-05	9.14e-05	CcSEcCtD
Cevimeline—Paraesthesia—Methylprednisolone—asthma	2.62e-05	9.14e-05	CcSEcCtD
Cevimeline—Anaemia—Prednisone—asthma	2.62e-05	9.13e-05	CcSEcCtD
Cevimeline—Shock—Betamethasone—asthma	2.61e-05	9.1e-05	CcSEcCtD
Cevimeline—Shock—Dexamethasone—asthma	2.61e-05	9.1e-05	CcSEcCtD
Cevimeline—Dyspnoea—Triamcinolone—asthma	2.61e-05	9.09e-05	CcSEcCtD
Cevimeline—Nervous system disorder—Dexamethasone—asthma	2.6e-05	9.08e-05	CcSEcCtD
Cevimeline—Nervous system disorder—Betamethasone—asthma	2.6e-05	9.08e-05	CcSEcCtD
Cevimeline—Agitation—Prednisone—asthma	2.6e-05	9.07e-05	CcSEcCtD
Cevimeline—Thrombocytopenia—Betamethasone—asthma	2.6e-05	9.06e-05	CcSEcCtD
Cevimeline—Thrombocytopenia—Dexamethasone—asthma	2.6e-05	9.06e-05	CcSEcCtD
Cevimeline—Tachycardia—Dexamethasone—asthma	2.59e-05	9.03e-05	CcSEcCtD
Cevimeline—Tachycardia—Betamethasone—asthma	2.59e-05	9.03e-05	CcSEcCtD
Cevimeline—Dyspepsia—Triamcinolone—asthma	2.57e-05	8.98e-05	CcSEcCtD
Cevimeline—Dyspepsia—Methylprednisolone—asthma	2.57e-05	8.96e-05	CcSEcCtD
Cevimeline—Hyperhidrosis—Dexamethasone—asthma	2.56e-05	8.95e-05	CcSEcCtD
Cevimeline—Hyperhidrosis—Betamethasone—asthma	2.56e-05	8.95e-05	CcSEcCtD
Cevimeline—Feeling abnormal—Hydrocortisone—asthma	2.56e-05	8.93e-05	CcSEcCtD
Cevimeline—Malaise—Prednisone—asthma	2.55e-05	8.9e-05	CcSEcCtD
Cevimeline—Vertigo—Prednisone—asthma	2.54e-05	8.87e-05	CcSEcCtD
Cevimeline—Gastrointestinal pain—Hydrocortisone—asthma	2.54e-05	8.86e-05	CcSEcCtD
Cevimeline—Syncope—Prednisone—asthma	2.54e-05	8.86e-05	CcSEcCtD
Cevimeline—Anorexia—Betamethasone—asthma	2.53e-05	8.82e-05	CcSEcCtD
Cevimeline—Anorexia—Dexamethasone—asthma	2.53e-05	8.82e-05	CcSEcCtD
Cevimeline—Urticaria—Prednisolone—asthma	2.52e-05	8.81e-05	CcSEcCtD
Cevimeline—Fatigue—Triamcinolone—asthma	2.52e-05	8.79e-05	CcSEcCtD
Cevimeline—Fatigue—Methylprednisolone—asthma	2.51e-05	8.77e-05	CcSEcCtD
Cevimeline—Pain—Triamcinolone—asthma	2.5e-05	8.72e-05	CcSEcCtD
Cevimeline—Loss of consciousness—Prednisone—asthma	2.49e-05	8.68e-05	CcSEcCtD
Cevimeline—Hypotension—Betamethasone—asthma	2.48e-05	8.65e-05	CcSEcCtD
Cevimeline—Hypotension—Dexamethasone—asthma	2.48e-05	8.65e-05	CcSEcCtD
Cevimeline—Urticaria—Hydrocortisone—asthma	2.47e-05	8.6e-05	CcSEcCtD
Cevimeline—Abdominal pain—Hydrocortisone—asthma	2.45e-05	8.56e-05	CcSEcCtD
Cevimeline—Body temperature increased—Hydrocortisone—asthma	2.45e-05	8.56e-05	CcSEcCtD
Cevimeline—Convulsion—Prednisone—asthma	2.45e-05	8.56e-05	CcSEcCtD
Cevimeline—Hypertension—Prednisone—asthma	2.44e-05	8.53e-05	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Betamethasone—asthma	2.42e-05	8.43e-05	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Dexamethasone—asthma	2.42e-05	8.43e-05	CcSEcCtD
Cevimeline—Arthralgia—Prednisone—asthma	2.41e-05	8.41e-05	CcSEcCtD
Cevimeline—Myalgia—Prednisone—asthma	2.41e-05	8.41e-05	CcSEcCtD
Cevimeline—Feeling abnormal—Triamcinolone—asthma	2.41e-05	8.4e-05	CcSEcCtD
Cevimeline—Feeling abnormal—Methylprednisolone—asthma	2.4e-05	8.39e-05	CcSEcCtD
Cevimeline—Anxiety—Prednisone—asthma	2.4e-05	8.38e-05	CcSEcCtD
Cevimeline—Insomnia—Betamethasone—asthma	2.4e-05	8.37e-05	CcSEcCtD
Cevimeline—Insomnia—Dexamethasone—asthma	2.4e-05	8.37e-05	CcSEcCtD
Cevimeline—Gastrointestinal pain—Methylprednisolone—asthma	2.38e-05	8.32e-05	CcSEcCtD
Cevimeline—Paraesthesia—Dexamethasone—asthma	2.38e-05	8.31e-05	CcSEcCtD
Cevimeline—Paraesthesia—Betamethasone—asthma	2.38e-05	8.31e-05	CcSEcCtD
Cevimeline—Discomfort—Prednisone—asthma	2.38e-05	8.31e-05	CcSEcCtD
Cevimeline—Hypersensitivity—Prednisolone—asthma	2.34e-05	8.17e-05	CcSEcCtD
Cevimeline—Dyspepsia—Dexamethasone—asthma	2.33e-05	8.15e-05	CcSEcCtD
Cevimeline—Dyspepsia—Betamethasone—asthma	2.33e-05	8.15e-05	CcSEcCtD
Cevimeline—Urticaria—Triamcinolone—asthma	2.32e-05	8.1e-05	CcSEcCtD
Cevimeline—Urticaria—Methylprednisolone—asthma	2.32e-05	8.08e-05	CcSEcCtD
Cevimeline—Body temperature increased—Triamcinolone—asthma	2.31e-05	8.06e-05	CcSEcCtD
Cevimeline—Oedema—Prednisone—asthma	2.31e-05	8.06e-05	CcSEcCtD
Cevimeline—Abdominal pain—Methylprednisolone—asthma	2.31e-05	8.04e-05	CcSEcCtD
Cevimeline—Decreased appetite—Betamethasone—asthma	2.31e-05	8.04e-05	CcSEcCtD
Cevimeline—Decreased appetite—Dexamethasone—asthma	2.31e-05	8.04e-05	CcSEcCtD
Cevimeline—Infection—Prednisone—asthma	2.29e-05	8.01e-05	CcSEcCtD
Cevimeline—Hypersensitivity—Hydrocortisone—asthma	2.29e-05	7.98e-05	CcSEcCtD
Cevimeline—Fatigue—Dexamethasone—asthma	2.29e-05	7.98e-05	CcSEcCtD
Cevimeline—Fatigue—Betamethasone—asthma	2.29e-05	7.98e-05	CcSEcCtD
Cevimeline—Shock—Prednisone—asthma	2.27e-05	7.93e-05	CcSEcCtD
Cevimeline—Pain—Dexamethasone—asthma	2.27e-05	7.91e-05	CcSEcCtD
Cevimeline—Pain—Betamethasone—asthma	2.27e-05	7.91e-05	CcSEcCtD
Cevimeline—Nervous system disorder—Prednisone—asthma	2.27e-05	7.9e-05	CcSEcCtD
Cevimeline—Tachycardia—Prednisone—asthma	2.25e-05	7.87e-05	CcSEcCtD
Cevimeline—Skin disorder—Prednisone—asthma	2.24e-05	7.83e-05	CcSEcCtD
Cevimeline—Hyperhidrosis—Prednisone—asthma	2.23e-05	7.79e-05	CcSEcCtD
Cevimeline—Asthenia—Hydrocortisone—asthma	2.23e-05	7.77e-05	CcSEcCtD
Cevimeline—Anorexia—Prednisone—asthma	2.2e-05	7.68e-05	CcSEcCtD
Cevimeline—Pruritus—Hydrocortisone—asthma	2.2e-05	7.66e-05	CcSEcCtD
Cevimeline—Feeling abnormal—Dexamethasone—asthma	2.19e-05	7.63e-05	CcSEcCtD
Cevimeline—Feeling abnormal—Betamethasone—asthma	2.19e-05	7.63e-05	CcSEcCtD
Cevimeline—Gastrointestinal pain—Betamethasone—asthma	2.17e-05	7.57e-05	CcSEcCtD
Cevimeline—Gastrointestinal pain—Dexamethasone—asthma	2.17e-05	7.57e-05	CcSEcCtD
Cevimeline—Hypersensitivity—Triamcinolone—asthma	2.15e-05	7.51e-05	CcSEcCtD
Cevimeline—Hypersensitivity—Methylprednisolone—asthma	2.15e-05	7.5e-05	CcSEcCtD
Cevimeline—Diarrhoea—Hydrocortisone—asthma	2.12e-05	7.41e-05	CcSEcCtD
Cevimeline—Urticaria—Dexamethasone—asthma	2.11e-05	7.35e-05	CcSEcCtD
Cevimeline—Urticaria—Betamethasone—asthma	2.11e-05	7.35e-05	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Prednisone—asthma	2.1e-05	7.34e-05	CcSEcCtD
Cevimeline—Dizziness—Prednisolone—asthma	2.1e-05	7.33e-05	CcSEcCtD
Cevimeline—Asthenia—Triamcinolone—asthma	2.1e-05	7.32e-05	CcSEcCtD
Cevimeline—Body temperature increased—Dexamethasone—asthma	2.1e-05	7.32e-05	CcSEcCtD
Cevimeline—Abdominal pain—Dexamethasone—asthma	2.1e-05	7.32e-05	CcSEcCtD
Cevimeline—Body temperature increased—Betamethasone—asthma	2.1e-05	7.32e-05	CcSEcCtD
Cevimeline—Abdominal pain—Betamethasone—asthma	2.1e-05	7.32e-05	CcSEcCtD
Cevimeline—Asthenia—Methylprednisolone—asthma	2.09e-05	7.3e-05	CcSEcCtD
Cevimeline—Insomnia—Prednisone—asthma	2.09e-05	7.29e-05	CcSEcCtD
Cevimeline—Paraesthesia—Prednisone—asthma	2.07e-05	7.24e-05	CcSEcCtD
Cevimeline—Pruritus—Triamcinolone—asthma	2.07e-05	7.22e-05	CcSEcCtD
Cevimeline—Pruritus—Methylprednisolone—asthma	2.06e-05	7.2e-05	CcSEcCtD
Cevimeline—Dizziness—Hydrocortisone—asthma	2.05e-05	7.16e-05	CcSEcCtD
Cevimeline—Dyspepsia—Prednisone—asthma	2.03e-05	7.09e-05	CcSEcCtD
Cevimeline—Decreased appetite—Prednisone—asthma	2.01e-05	7.01e-05	CcSEcCtD
Cevimeline—Rash—Prednisolone—asthma	2e-05	6.99e-05	CcSEcCtD
Cevimeline—Dermatitis—Prednisolone—asthma	2e-05	6.99e-05	CcSEcCtD
Cevimeline—Diarrhoea—Methylprednisolone—asthma	2e-05	6.96e-05	CcSEcCtD
Cevimeline—Fatigue—Prednisone—asthma	1.99e-05	6.95e-05	CcSEcCtD
Cevimeline—Headache—Prednisolone—asthma	1.99e-05	6.95e-05	CcSEcCtD
Cevimeline—Constipation—Prednisone—asthma	1.98e-05	6.89e-05	CcSEcCtD
Cevimeline—Vomiting—Hydrocortisone—asthma	1.97e-05	6.89e-05	CcSEcCtD
Cevimeline—Rash—Hydrocortisone—asthma	1.96e-05	6.83e-05	CcSEcCtD
Cevimeline—Dermatitis—Hydrocortisone—asthma	1.96e-05	6.82e-05	CcSEcCtD
Cevimeline—Headache—Hydrocortisone—asthma	1.94e-05	6.79e-05	CcSEcCtD
Cevimeline—Dizziness—Triamcinolone—asthma	1.93e-05	6.74e-05	CcSEcCtD
Cevimeline—Dizziness—Methylprednisolone—asthma	1.93e-05	6.73e-05	CcSEcCtD
Cevimeline—CHRM1—Signaling Pathways—CCL11—asthma	1.91e-05	0.000395	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—DCN—asthma	1.9e-05	0.000394	CbGpPWpGaD
Cevimeline—Feeling abnormal—Prednisone—asthma	1.9e-05	6.64e-05	CcSEcCtD
Cevimeline—Asthenia—Betamethasone—asthma	1.9e-05	6.64e-05	CcSEcCtD
Cevimeline—Asthenia—Dexamethasone—asthma	1.9e-05	6.64e-05	CcSEcCtD
Cevimeline—CHRM1—Signaling by GPCR—AGTR1—asthma	1.9e-05	0.000394	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—VIP—asthma	1.9e-05	0.000394	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CMA1—asthma	1.9e-05	0.000394	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—C5AR1—asthma	1.9e-05	0.000394	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—UTS2—asthma	1.9e-05	0.000394	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CCL11—asthma	1.9e-05	0.000394	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—AGTR1—asthma	1.9e-05	0.000393	CbGpPWpGaD
Cevimeline—Gastrointestinal pain—Prednisone—asthma	1.89e-05	6.59e-05	CcSEcCtD
Cevimeline—Nausea—Prednisolone—asthma	1.89e-05	6.59e-05	CcSEcCtD
Cevimeline—CHRM1—GPCR downstream signaling—ITPR1—asthma	1.88e-05	0.000389	CbGpPWpGaD
Cevimeline—Pruritus—Dexamethasone—asthma	1.88e-05	6.55e-05	CcSEcCtD
Cevimeline—Pruritus—Betamethasone—asthma	1.88e-05	6.55e-05	CcSEcCtD
Cevimeline—CHRM3—GPCR downstream signaling—ITPR1—asthma	1.87e-05	0.000388	CbGpPWpGaD
Cevimeline—Vomiting—Triamcinolone—asthma	1.86e-05	6.48e-05	CcSEcCtD
Cevimeline—CHRM1—Signaling by GPCR—CXCL10—asthma	1.86e-05	0.000385	CbGpPWpGaD
Cevimeline—Vomiting—Methylprednisolone—asthma	1.85e-05	6.47e-05	CcSEcCtD
Cevimeline—CHRM3—Signaling by GPCR—CXCL10—asthma	1.85e-05	0.000384	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ALDH2—asthma	1.85e-05	0.000384	CbGpPWpGaD
Cevimeline—Nausea—Hydrocortisone—asthma	1.84e-05	6.43e-05	CcSEcCtD
Cevimeline—Rash—Triamcinolone—asthma	1.84e-05	6.43e-05	CcSEcCtD
Cevimeline—Dermatitis—Triamcinolone—asthma	1.84e-05	6.42e-05	CcSEcCtD
Cevimeline—Rash—Methylprednisolone—asthma	1.84e-05	6.42e-05	CcSEcCtD
Cevimeline—Dermatitis—Methylprednisolone—asthma	1.84e-05	6.41e-05	CcSEcCtD
Cevimeline—Urticaria—Prednisone—asthma	1.83e-05	6.4e-05	CcSEcCtD
Cevimeline—Headache—Triamcinolone—asthma	1.83e-05	6.39e-05	CcSEcCtD
Cevimeline—CHRM1—Signaling Pathways—CCR4—asthma	1.83e-05	0.000379	CbGpPWpGaD
Cevimeline—Headache—Methylprednisolone—asthma	1.83e-05	6.38e-05	CcSEcCtD
Cevimeline—Body temperature increased—Prednisone—asthma	1.83e-05	6.37e-05	CcSEcCtD
Cevimeline—Abdominal pain—Prednisone—asthma	1.83e-05	6.37e-05	CcSEcCtD
Cevimeline—CHRM3—Signaling Pathways—CCR4—asthma	1.82e-05	0.000377	CbGpPWpGaD
Cevimeline—Diarrhoea—Dexamethasone—asthma	1.81e-05	6.33e-05	CcSEcCtD
Cevimeline—Diarrhoea—Betamethasone—asthma	1.81e-05	6.33e-05	CcSEcCtD
Cevimeline—CYP3A4—Biological oxidations—POMC—asthma	1.81e-05	0.000376	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—ADRB2—asthma	1.8e-05	0.000374	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—ADRB2—asthma	1.8e-05	0.000373	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ALDH7A1—asthma	1.79e-05	0.000371	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—STAT6—asthma	1.79e-05	0.000371	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—STAT6—asthma	1.79e-05	0.00037	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—IL6—asthma	1.78e-05	0.00037	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—EDN1—asthma	1.78e-05	0.000368	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—EDN1—asthma	1.77e-05	0.000367	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GSTT1—asthma	1.76e-05	0.000365	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—CCL5—asthma	1.76e-05	0.000365	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IL2RB—asthma	1.76e-05	0.000364	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—CCL5—asthma	1.76e-05	0.000364	CbGpPWpGaD
Cevimeline—Dizziness—Betamethasone—asthma	1.75e-05	6.12e-05	CcSEcCtD
Cevimeline—Dizziness—Dexamethasone—asthma	1.75e-05	6.12e-05	CcSEcCtD
Cevimeline—CHRM3—Signaling Pathways—IL2RB—asthma	1.75e-05	0.000363	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PDE4D—asthma	1.74e-05	0.000361	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PDE4D—asthma	1.74e-05	0.00036	CbGpPWpGaD
Cevimeline—Nausea—Triamcinolone—asthma	1.74e-05	6.06e-05	CcSEcCtD
Cevimeline—CHRM1—GPCR downstream signaling—CSF2—asthma	1.74e-05	0.000359	CbGpPWpGaD
Cevimeline—Nausea—Methylprednisolone—asthma	1.73e-05	6.04e-05	CcSEcCtD
Cevimeline—CHRM3—GPCR downstream signaling—CSF2—asthma	1.73e-05	0.000358	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ARG2—asthma	1.72e-05	0.000356	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—LTC4S—asthma	1.71e-05	0.000354	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—ITPR1—asthma	1.71e-05	0.000353	CbGpPWpGaD
Cevimeline—Hypersensitivity—Prednisone—asthma	1.7e-05	5.94e-05	CcSEcCtD
Cevimeline—CHRM3—Signaling by GPCR—ITPR1—asthma	1.7e-05	0.000352	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—C5—asthma	1.7e-05	0.000352	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PDE4B—asthma	1.7e-05	0.000352	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TACR1—asthma	1.7e-05	0.000352	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—CXCL8—asthma	1.7e-05	0.000352	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—C5—asthma	1.69e-05	0.000351	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TACR1—asthma	1.69e-05	0.000351	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PDE4B—asthma	1.69e-05	0.000351	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—CXCL8—asthma	1.69e-05	0.000351	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—asthma	1.69e-05	0.00035	CbGpPWpGaD
Cevimeline—Vomiting—Betamethasone—asthma	1.69e-05	5.88e-05	CcSEcCtD
Cevimeline—Vomiting—Dexamethasone—asthma	1.69e-05	5.88e-05	CcSEcCtD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—asthma	1.69e-05	0.000349	CbGpPWpGaD
Cevimeline—Rash—Betamethasone—asthma	1.67e-05	5.83e-05	CcSEcCtD
Cevimeline—Rash—Dexamethasone—asthma	1.67e-05	5.83e-05	CcSEcCtD
Cevimeline—Dermatitis—Betamethasone—asthma	1.67e-05	5.83e-05	CcSEcCtD
Cevimeline—Dermatitis—Dexamethasone—asthma	1.67e-05	5.83e-05	CcSEcCtD
Cevimeline—Headache—Dexamethasone—asthma	1.66e-05	5.8e-05	CcSEcCtD
Cevimeline—Headache—Betamethasone—asthma	1.66e-05	5.8e-05	CcSEcCtD
Cevimeline—Asthenia—Prednisone—asthma	1.66e-05	5.78e-05	CcSEcCtD
Cevimeline—Pruritus—Prednisone—asthma	1.63e-05	5.7e-05	CcSEcCtD
Cevimeline—CHRM1—Signaling by GPCR—EDN1—asthma	1.61e-05	0.000334	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—EDN1—asthma	1.61e-05	0.000333	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CCL5—asthma	1.6e-05	0.000331	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CCL5—asthma	1.59e-05	0.00033	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PLA2G4A—asthma	1.59e-05	0.00033	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PLA2G4A—asthma	1.59e-05	0.000329	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—CCR5—asthma	1.59e-05	0.000329	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—CCR5—asthma	1.58e-05	0.000328	CbGpPWpGaD
Cevimeline—Diarrhoea—Prednisone—asthma	1.58e-05	5.51e-05	CcSEcCtD
Cevimeline—CHRM1—Signaling by GPCR—CSF2—asthma	1.58e-05	0.000326	CbGpPWpGaD
Cevimeline—Nausea—Dexamethasone—asthma	1.58e-05	5.5e-05	CcSEcCtD
Cevimeline—Nausea—Betamethasone—asthma	1.58e-05	5.5e-05	CcSEcCtD
Cevimeline—CHRM3—Signaling by GPCR—CSF2—asthma	1.57e-05	0.000325	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—IL2RA—asthma	1.56e-05	0.000324	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—IL2RA—asthma	1.56e-05	0.000323	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CCR3—asthma	1.55e-05	0.000322	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—C3—asthma	1.55e-05	0.000321	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CCR3—asthma	1.55e-05	0.000321	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—C3—asthma	1.55e-05	0.00032	CbGpPWpGaD
Cevimeline—Dizziness—Prednisone—asthma	1.53e-05	5.33e-05	CcSEcCtD
Cevimeline—CHRM1—Signaling Pathways—NPY—asthma	1.51e-05	0.000314	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NPY—asthma	1.51e-05	0.000313	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—LTA4H—asthma	1.48e-05	0.000307	CbGpPWpGaD
Cevimeline—Vomiting—Prednisone—asthma	1.47e-05	5.12e-05	CcSEcCtD
Cevimeline—CHRM1—Signaling by GPCR—PPP2CA—asthma	1.47e-05	0.000304	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—NQO1—asthma	1.46e-05	0.000303	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PPP2CA—asthma	1.46e-05	0.000303	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—AGTR2—asthma	1.46e-05	0.000303	CbGpPWpGaD
Cevimeline—Rash—Prednisone—asthma	1.46e-05	5.08e-05	CcSEcCtD
Cevimeline—CHRM3—Signaling Pathways—AGTR2—asthma	1.46e-05	0.000302	CbGpPWpGaD
Cevimeline—Dermatitis—Prednisone—asthma	1.45e-05	5.08e-05	CcSEcCtD
Cevimeline—Headache—Prednisone—asthma	1.45e-05	5.05e-05	CcSEcCtD
Cevimeline—CHRM1—Signaling by GPCR—CCR5—asthma	1.44e-05	0.000299	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CCR5—asthma	1.44e-05	0.000298	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ADCY2—asthma	1.43e-05	0.000297	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ALOX5AP—asthma	1.42e-05	0.000295	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ALOX15—asthma	1.42e-05	0.000295	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—IL2RA—asthma	1.42e-05	0.000294	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—IL2RA—asthma	1.42e-05	0.000293	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—C3—asthma	1.41e-05	0.000292	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—C3—asthma	1.4e-05	0.000291	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—EDNRB—asthma	1.4e-05	0.00029	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—EDNRB—asthma	1.39e-05	0.000289	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TAC1—asthma	1.38e-05	0.000287	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NPS—asthma	1.38e-05	0.000287	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TAC1—asthma	1.38e-05	0.000286	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NPS—asthma	1.38e-05	0.000286	CbGpPWpGaD
Cevimeline—Nausea—Prednisone—asthma	1.37e-05	4.79e-05	CcSEcCtD
Cevimeline—CYP2D6—Metabolism—CHAT—asthma	1.36e-05	0.000281	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CXCR3—asthma	1.36e-05	0.000281	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CXCR3—asthma	1.35e-05	0.00028	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CYBA—asthma	1.32e-05	0.000272	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CYBA—asthma	1.31e-05	0.000272	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ARG1—asthma	1.3e-05	0.000268	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IL5—asthma	1.29e-05	0.000267	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PARP1—asthma	1.29e-05	0.000267	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PARP1—asthma	1.28e-05	0.000266	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IL5—asthma	1.28e-05	0.000266	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—BDKRB2—asthma	1.24e-05	0.000257	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—POMC—asthma	1.24e-05	0.000257	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—BDKRB2—asthma	1.24e-05	0.000257	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—POMC—asthma	1.24e-05	0.000256	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GSTP1—asthma	1.22e-05	0.000253	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ALOX5—asthma	1.21e-05	0.000251	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—HMOX1—asthma	1.2e-05	0.00025	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ADCY2—asthma	1.2e-05	0.000249	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ITPR1—asthma	1.2e-05	0.000249	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ADCY2—asthma	1.2e-05	0.000248	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IL3—asthma	1.2e-05	0.000248	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IL3—asthma	1.19e-05	0.000247	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CAT—asthma	1.19e-05	0.000246	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ALDH7A1—asthma	1.17e-05	0.000243	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CARM1—asthma	1.16e-05	0.000239	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—DCN—asthma	1.14e-05	0.000236	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—KNG1—asthma	1.13e-05	0.000234	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—KNG1—asthma	1.13e-05	0.000233	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—POMC—asthma	1.13e-05	0.000233	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ARG2—asthma	1.12e-05	0.000233	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—AGTR1—asthma	1.12e-05	0.000233	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—POMC—asthma	1.12e-05	0.000233	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PLA2G4A—asthma	1.12e-05	0.000232	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GSTM1—asthma	1.12e-05	0.000232	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—AGTR1—asthma	1.12e-05	0.000232	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ALDH2—asthma	1.11e-05	0.000229	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CCL2—asthma	1.1e-05	0.000228	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—IL6R—asthma	1.1e-05	0.000228	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CCL2—asthma	1.1e-05	0.000228	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CXCL10—asthma	1.1e-05	0.000227	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—IL6R—asthma	1.1e-05	0.000227	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CXCL10—asthma	1.09e-05	0.000227	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—RHOA—asthma	1.09e-05	0.000226	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—RHOA—asthma	1.09e-05	0.000226	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NTRK1—asthma	1.08e-05	0.000223	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NTRK1—asthma	1.07e-05	0.000222	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ADRB2—asthma	1.07e-05	0.000221	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ADRB2—asthma	1.06e-05	0.00022	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GSTT1—asthma	1.05e-05	0.000218	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PPP2CA—asthma	1.03e-05	0.000214	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ITPR1—asthma	1.01e-05	0.000209	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ITPR1—asthma	1e-05	0.000208	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—RHOA—asthma	9.92e-06	0.000206	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—RHOA—asthma	9.89e-06	0.000205	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CD86—asthma	9.6e-06	0.000199	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—CXCL8—asthma	9.59e-06	0.000199	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CD86—asthma	9.57e-06	0.000198	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—CXCL8—asthma	9.56e-06	0.000198	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—EDN1—asthma	9.52e-06	0.000197	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—EDN1—asthma	9.49e-06	0.000197	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CCL5—asthma	9.45e-06	0.000196	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CCL5—asthma	9.42e-06	0.000195	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PLA2G4A—asthma	9.41e-06	0.000195	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PLA2G4A—asthma	9.38e-06	0.000194	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ALOX5AP—asthma	9.31e-06	0.000193	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ALOX15—asthma	9.31e-06	0.000193	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CSF2—asthma	9.31e-06	0.000193	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CSF2—asthma	9.28e-06	0.000192	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—IL2—asthma	9.17e-06	0.00019	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—IL2—asthma	9.14e-06	0.000189	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SMAD3—asthma	9.06e-06	0.000188	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SMAD3—asthma	9.03e-06	0.000187	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CHAT—asthma	8.88e-06	0.000184	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—NQO1—asthma	8.75e-06	0.000181	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CXCL8—asthma	8.71e-06	0.000181	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CXCL8—asthma	8.68e-06	0.00018	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PPP2CA—asthma	8.67e-06	0.00018	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PPP2CA—asthma	8.64e-06	0.000179	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ADCY2—asthma	8.57e-06	0.000177	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CCR5—asthma	8.51e-06	0.000176	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CCR5—asthma	8.49e-06	0.000176	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IL2RA—asthma	8.39e-06	0.000174	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IL2RA—asthma	8.36e-06	0.000173	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—IL2—asthma	8.33e-06	0.000173	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—C3—asthma	8.32e-06	0.000172	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—IL2—asthma	8.3e-06	0.000172	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—C3—asthma	8.29e-06	0.000172	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PDGFB—asthma	8.1e-06	0.000168	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PDGFB—asthma	8.07e-06	0.000167	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—POMC—asthma	7.93e-06	0.000164	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ALOX5—asthma	7.92e-06	0.000164	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—LEP—asthma	7.74e-06	0.00016	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—LEP—asthma	7.72e-06	0.00016	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CARM1—asthma	7.55e-06	0.000156	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—DCN—asthma	7.44e-06	0.000154	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—FN1—asthma	7.3e-06	0.000151	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GSTP1—asthma	7.3e-06	0.000151	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—FN1—asthma	7.28e-06	0.000151	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ALDH2—asthma	7.24e-06	0.00015	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ALB—asthma	7.23e-06	0.00015	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—HMOX1—asthma	7.2e-06	0.000149	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ITPR1—asthma	7.18e-06	0.000149	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CAT—asthma	7.11e-06	0.000147	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—NOS3—asthma	6.92e-06	0.000143	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GSTT1—asthma	6.89e-06	0.000143	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PLA2G4A—asthma	6.71e-06	0.000139	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GSTM1—asthma	6.71e-06	0.000139	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—POMC—asthma	6.65e-06	0.000138	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—POMC—asthma	6.63e-06	0.000137	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CCL2—asthma	6.51e-06	0.000135	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IL6R—asthma	6.49e-06	0.000134	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CCL2—asthma	6.49e-06	0.000134	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IL6R—asthma	6.47e-06	0.000134	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—EGFR—asthma	6.37e-06	0.000132	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—EGFR—asthma	6.35e-06	0.000132	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PTGS2—asthma	6.33e-06	0.000131	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PPP2CA—asthma	6.18e-06	0.000128	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SERPINE1—asthma	6.08e-06	0.000126	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SERPINE1—asthma	6.06e-06	0.000126	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—RHOA—asthma	5.86e-06	0.000121	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—RHOA—asthma	5.84e-06	0.000121	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NOS3—asthma	5.8e-06	0.00012	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NOS3—asthma	5.78e-06	0.00012	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NQO1—asthma	5.72e-06	0.000119	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ADCY2—asthma	5.6e-06	0.000116	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PTEN—asthma	5.52e-06	0.000114	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CXCL8—asthma	5.15e-06	0.000107	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CXCL8—asthma	5.13e-06	0.000106	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IL2—asthma	4.92e-06	0.000102	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IL2—asthma	4.9e-06	0.000102	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—IL6—asthma	4.89e-06	0.000101	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—IL6—asthma	4.88e-06	0.000101	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GSTP1—asthma	4.77e-06	9.89e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—POMC—asthma	4.74e-06	9.83e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—HMOX1—asthma	4.71e-06	9.75e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ITPR1—asthma	4.7e-06	9.73e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MMP9—asthma	4.66e-06	9.64e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CAT—asthma	4.65e-06	9.62e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MMP9—asthma	4.64e-06	9.61e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PTEN—asthma	4.63e-06	9.59e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PTEN—asthma	4.61e-06	9.56e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GSTM1—asthma	4.39e-06	9.09e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PLA2G4A—asthma	4.39e-06	9.09e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ALB—asthma	4.32e-06	8.96e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—VEGFA—asthma	4.18e-06	8.66e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—VEGFA—asthma	4.17e-06	8.63e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—STAT3—asthma	4.14e-06	8.58e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—NOS3—asthma	4.14e-06	8.57e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—STAT3—asthma	4.13e-06	8.55e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PPP2CA—asthma	4.04e-06	8.37e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TGFB1—asthma	3.84e-06	7.95e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TGFB1—asthma	3.82e-06	7.92e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PTGS2—asthma	3.78e-06	7.84e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—EGFR—asthma	3.76e-06	7.79e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—EGFR—asthma	3.75e-06	7.77e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PTEN—asthma	3.3e-06	6.83e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—POMC—asthma	3.1e-06	6.42e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IL6—asthma	2.89e-06	5.99e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IL6—asthma	2.88e-06	5.97e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ALB—asthma	2.83e-06	5.86e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NOS3—asthma	2.7e-06	5.6e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PTGS2—asthma	2.47e-06	5.12e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PTEN—asthma	2.16e-06	4.47e-05	CbGpPWpGaD
